Recurrent Solid Neoplasm

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB08885	Aflibercept	1	Recruiting	1
DB08912	Dabrafenib	1	Recruiting	1
DB00762	Irinotecan	1	Recruiting	1
DB06132	Nivolumab	1	Recruiting	1
DB09035	Nivolumab	1	Recruiting	1
DB06306	Onalespib	1	Recruiting	1
DB06176	Romidepsin	1	Recruiting	1
DB11836	Sapanisertib	1	Recruiting	1
DB00853	Temozolomide	1	Recruiting	1
DB08911	Trametinib	1	Recruiting	1
DB07232	Veliparib	1	Recruiting	1
DB00515	Cisplatin	1 / 2	Recruiting	1
DB06186	Ipilimumab	1 / 2	Recruiting	1
DB00762	Irinotecan	1 / 2	Recruiting	1
DB11740	MK-1775	1 / 2	Recruiting	1
DB06328	Methoxyamine	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Recruiting	1
DB00642	Pemetrexed	1 / 2	Recruiting	1
DB12257	Platinum	1 / 2	Recruiting	1
DB08916	Afatinib	2	Recruiting	1
DB08875	Cabozantinib	2	Recruiting	1
DB00958	Carboplatin	2	Suspended	1
DB08865	Crizotinib	2	Recruiting	1
DB08912	Dabrafenib	2	Recruiting	1
DB01254	Dasatinib	2	Recruiting	1
DB01590	Everolimus	2	Suspended	1
DB11740	MK-1775	2	Suspended	1
DB09035	Nivolumab	2	Recruiting	1
DB09330	Osimertinib	2	Recruiting	1
DB09073	Palbociclib	2	Recruiting	1
DB06366	Pertuzumab	2	Recruiting	1
DB01268	Sunitinib	2	Recruiting	1
DB12108	Taselisib	2	Recruiting	1
DB00853	Temozolomide	2	Suspended	1
DB08911	Trametinib	2	Recruiting	1
DB08911	Trametinib	2	Suspended	1
DB00072	Trastuzumab	2	Recruiting	1
DB05773	Trastuzumab emtansine	2	Recruiting	1
DB07232	Veliparib	2	Suspended	1
DB08828	Vismodegib	2	Recruiting	1